Procurement of Multitron HT Incubator
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA), specifically the Division of Product Quality Research (DPQR) at the Advanced Manufacturing Research Facility (AMRF) in Beltsville, MD, is conducting a Sources Sought market survey for a Multitron HT Incubator system. This equipment is required to support mammalian cell culture at production-relevant volumes. Responses are due by April 17, 2026, 12:00 PM.
Purpose & Scope
The FDA seeks to identify vendors capable of providing a commercially available incubator shaker system that supports mammalian cell culture under controlled environmental and agitation conditions. The current equipment lacks sufficient capacity for large-volume cultures (e.g., 5-liter flasks) and operational needs. The system must be compatible with existing Chinese hamster ovary (CHO) suspension culture processes and provide sufficient capacity and flexibility without requiring changes to existing protocols.
Key Requirements
The required system is a triple-stack incubator shaker with independent control for temperature, CO₂, humidity, and orbital shaking in each unit. It must be compatible with 5-L Erlenmeyer shake flasks and include features such as adjustable orbital shaking, integrated humidity and CO₂ control, UV sterilization, a dark observation window, and a cable passthrough port. The solution must be UL certified. Associated services include IQ/OQ documentation, on-site installation, and training for 1-3 end-users.
Contract & Timeline
This is a Sources Sought Notice for market research purposes only; it is not a solicitation, and no contract will be awarded from this notice. No reimbursement will be made for costs associated with providing information.
- Opportunity Type: Sources Sought
- Published Date: April 14, 2026
- Response Due: April 17, 2026, 12:00 PM
Eligibility & Submission
Responses are encouraged from both small and other than small businesses. The primary NAICS Code is 334516 (Analytical Laboratory Instrument Manufacturing), with a Small Business Size Standard of 1,000 employees. Interested vendors must submit a capability statement, not exceeding 10 pages (PDF or Microsoft Word), demonstrating their ability to meet the technical requirements. Submissions should include:
- Company name, address, CAGE Code, and UEI.
- Recommended NAICS code for the equipment.
- Company size and socio-economic status (if applicable).
- GSA Schedule or other government-wide contract information.
- Domestic manufacturing status.
- Technical specifications for the proposed solution.
Submission Instructions
Capability statements must be emailed to Reagan.Davis@fda.hhs.gov. The subject line must be: "Sources Sought Notice Number: SSN_ CDER-2026-133237 Multitron HT Incubator."
Evaluation
Responses will be used to determine industry capabilities and potential small business participation. The FDA will not provide feedback on submitted capabilities. Proprietary information should not be submitted.